2023-09-25 17:21:32
During the last wave of Covid, last winter, only 55,000 patients benefited from Paxlovid. JOE RAEDLE / Getty Images via AFP
DECRYPTION – As the number of cases starts to rise again, general practitioners and pharmacists can obtain support for prescribing antiviral treatment.
Two pink tablets and one white tablet, taken twice daily for five days, reduce the risk of hospitalization and death in the most vulnerable Covid patients by almost 90%. The effectiveness of Paxlovid, demonstrated in clinical trials, has been confirmed by several studies since its authorization in January 2022. But cet antiviral remains little used: during the last wave, last winter, it was delivered to fewer than 55,000 patients. Another curative treatment, Remdesivir, can also be offered to people at risk of developing a severe form of Covid, but it must be administered intravenously under strict medical supervision. « We are seeing too many hospitalizations for Covid-19 that could have been avoided with available treatments »comments Antoine Flahault, epidemiologist and professor of public health at the University of Geneva.
Five days after the first symptoms
The still rare use of Paxlovid (combination of nirmatrelvir…
This article is reserved for subscribers. You have 79% left to discover.
Flash Sale -70%
Offer available until September 25. Without engagement.
Already subscribed? Log in
#Paxlovid #effective #treatment #forms #prescribed